Suggested Use
Humulin N is indicated for:
- Improving glycemic control in adults and paediatric patients with diabetes mellitus.
- It functions by stimulating glucose uptake in muscle and fat cells while inhibiting glucose production in the liver, thereby lowering blood sugar levels.
Dosage:
- The typical dosage of Humulin N varies based on individual needs and should be determined by a healthcare provider.
- It is usually administered via subcutaneous injection.
- The onset of action typically occurs within 1 to 2 hours, with peak effects at approximately 6 to 8 hours, and a duration of action lasting up to 18 hours
Warning
- Hypoglycemia: There is a risk of low blood sugar, especially if doses are not adjusted according to dietary intake or physical activity.
- Injection Site Reactions: Patients should rotate injection sites to minimize local reactions.
- Medical Conditions: Consult a healthcare provider if you have conditions such as kidney or liver disease, or if you are pregnant or breastfeeding.
- Do Not Share: Syringes should not be shared between patients to prevent infections.
Patients are advised to closely monitor their blood glucose levels and adjust their dosage as necessary under medical supervision.
